Siflon Drugs Profile
Key Indicators
- Authorised Capital ₹ 6.15 Cr
- Paid Up Capital ₹ 6.15 Cr
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.23 Cr
- Satisfied Charges ₹ 4.96 Cr
- Revenue Growth -31.50%
- Profit Growth -412.74%
- Ebitda -1109.61%
- Net Worth -84.65%
- Total Assets -0.31%
About Siflon Drugs
Siflon Drugs Private Limited (SDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 March 2010 and has a history of 14 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.15 Cr and a paid-up capital of Rs 6.15 Cr.
The company currently has active open charges totaling ₹30.23 Cr. The company has closed loans amounting to ₹4.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Swetha Rallapalli, Parvathi Rallapalli, and Ananthaiah Rallapalli serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232TG2010PTC067606
- Company No.
067606
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Siflon Drugs Private Limited offer?
Siflon Drugs Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Anthelmintics, Pharma Ingredients & Raw Materials, API Intermediate, Anti Infective API, PVC, FRP, HDPE & Other Plastic Pipes, Industrial Plastic Pipes, Industrial Valves & Valve Fittings, Lined Valves, Metal Pipe & Plumbing Fittings.
Who are the key members and board of directors at Siflon Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ananthaiah Rallapalli  | Managing Director | 19-Mar-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swetha Rallapalli | Director | 19-Mar-2010 | Current |
| Parvathi Rallapalli | Director | 19-Mar-2010 | Current |
Financial Performance of Siflon Drugs.
Siflon Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.5% decrease. The company also saw a substantial fall in profitability, with a 412.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 84.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siflon Drugs?
In 2023, Siflon Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Siflon Polymers Private LimitedSwetha Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Siflon Pharma Private LimitedSwetha Rallapalli, Parvathi Rallapalli and 1 more are mutual person
- Manoj Animal Health Private Limited
Swetha Rallapalli, Parvathi Rallapalli and 1 more are mutual person
- Siflon Engineering Private Limited
Swetha Rallapalli, Parvathi Rallapalli and 1 more are mutual person
Charges (Loans)
₹30.23 Cr
₹4.96 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 30.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2019 | Axis Bank Limited | ₹3.45 Cr | Open |
| 30 Jul 2015 | Axis Bank Limited | ₹1.78 Cr | Open |
| 30 Jul 2015 | Axis Bank Limited | ₹25.00 Cr | Open |
| 09 May 2011 | Oriental Bank Of Commerce | ₹4.96 Cr | Satisfied |
How Many Employees Work at Siflon Drugs?
Siflon Drugs has a workforce of 46 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siflon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siflon Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.